December 21, 2004
Flamel Technologies Announces Completion of a Commercial Supply Agreement with Glaxo-Smith Kline for Drug in Phase III Trials

December 17, 2004
Flamel Technologies Announces Initiation of Phase I/II trial of Medusa Formulation of Long-Acting Interferon-alpha for Hepatitis B and Hepatitis C Treatment

December 8, 2004
Flamel Technologies Announces Initiation of Phase I/II trial of Medusa Formulation of Long-Acting Interleukin-2 for Cancer Treatment

October 28, 2004
Flamel Technologies Announces Third Quarter Results
Transcript of the conference call

October 25, 2004
Flamel Technologies Announces Projected Release Date of Third Quarter, Conference Call

September 16, 2004
Flamel Technologies Announces the License of Flamel's Micropump Technology to TAP Pharmaceutical Products Inc. for Lansoprazole, Conference Call
Webcast

September 16, 2004
Flamel Technologies Announces Initiation of Phase III trial for Micropump Formulation of a GlaxoSmithKline Product, Conference Call
Webcast

September 16, 2004
Flamel Technologies Announces Termination of License Agreement for Long-Acting Insulin, Conference Call
Webcast

July 29, 2004
Flamel Technologies Announces Second Quarter Revenues of $9.0 Million, Cash at $101 Million
Webcast for Q2 2004
Replay of the CC: (800) 642-1687 (US) or (706) 645-9291 (international)
conference ID: 8771969
Transcript of the conference call

July 26, 2004
Flamel Technologies Announces Projected Release Date of Second Quarter Results, Conference Call

July 1, 2004
Flamel Technologies Announces Selection of a Flamel Micropump Formulation to Progress to Phase III Clinical Trials

April 29, 2004
Flamel Technologies Announces First Quarter Revenues of $14.4 Million, Earnings of $0.20 Per Share

April 26, 2004
Flamel Technologies Announces Projected Release Date of First Quarter Results, Conference Call

April 1, 2004
Flamel Technologies announces receipt of $5 million milestone payment from Bristol-Myers Squibb Company

March 11, 2004
Flamel Technologies announces fourth quarter and year end 2003 results

March 4, 2004
Flamel Technologies announces projected release date of fourth quarter and year end results, conference call

January 5, 2004
Flamel Technologies announces receipt of milestone payment from GlaxoSmithKline